Rosiglitazone hydrochloride, CAS [[302543-62-0]]

Produktübersicht

• Artikelname: Rosiglitazone hydrochloride, CAS [[302543-62-0]]
• Artikelnummer: BYT-ORB1300588
• Hersteller Artikelnummer: orb1300588
• Alternativnummer: BYT-ORB1300588-1,BYT-ORB1300588-100,BYT-ORB1300588-200,BYT-ORB1300588-25,BYT-ORB1300588-50,BYT-ORB1300588-500
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: carcinoma, cancer, bladder, Autophagy, antihyperglycemic, Apoptosis, diabetes, diabetic, BRL 49653, BRL49653, BRL-49653, BRL-49653 HCl, Inhibitor, inhibit, neuroprotection, ovarian cancer, hepatocellular, HCC, mellitus, Ferroptosis, senescence, Peroxisome proliferator-activated receptors, PPAR, PPARgamma, TRPV Channel, TRPChannel, TRPVChannel, TRP Channel, Transient receptor potential channels, Rosiglitazone, Rosiglitazone HCl, Rosiglitazone hydrochloride, Rosiglitazone Hydrochloride, smoke

Produktbeschreibung

Rosiglitazone hydrochloride is a PPARgamma agonist that enhances insulin sensitivity, primarily used in diabetes research. It is widely applied in both in vitro receptor binding assays and in vivo models of insulin resistance and glucose metabolism studies.

Produkteigenschaften

• Molekulargewicht: 393.89
• Reinheit: 99.79% (May vary between batches)
• CAS Nummer: [302543-62-0]
• Formel: C18H19N3O3SHCl
• Target-Kategorie: TRP/TRPV Channel,Ferroptosis,Apoptosis,PPAR,Autophagy

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: H2O:< 1 mg/mL (insoluble or slightly soluble),DMSO:250 mg/mL (634.69 mM),Ethanol:73 mg/mL (185.33 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:10 mg/mL (25.39 mM)